Raymond James Financial Services Advisors Inc. purchased a new position in shares of Cantel Medical Corp. (NYSE:CMD) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 6,842 shares of the company’s stock, valued at approximately $644,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Globeflex Capital L P purchased a new stake in shares of Cantel Medical during the 2nd quarter worth about $114,000. LS Investment Advisors LLC purchased a new stake in shares of Cantel Medical during the 2nd quarter worth about $172,000. Airain ltd purchased a new stake in shares of Cantel Medical during the 2nd quarter worth about $201,000. Punch & Associates Investment Management Inc. bought a new position in shares of Cantel Medical in the 2nd quarter valued at approximately $212,000. Finally, Riverhead Capital Management LLC bought a new position in shares of Cantel Medical in the 2nd quarter valued at approximately $218,000. 84.98% of the stock is owned by institutional investors.

Cantel Medical Corp. (NYSE:CMD) opened at $103.38 on Tuesday. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24. Cantel Medical Corp. has a one year low of $69.21 and a one year high of $108.00. The firm has a market capitalization of $4,451.49, a P/E ratio of 51.19 and a beta of 1.24.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings data on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.02. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. The business had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. The firm’s revenue was up 14.8% compared to the same quarter last year. research analysts predict that Cantel Medical Corp. will post 2.34 earnings per share for the current fiscal year.

The business also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a $0.085 dividend. This represents a dividend yield of 0.17%. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. The ex-dividend date of this dividend is Tuesday, January 16th. Cantel Medical’s dividend payout ratio (DPR) is presently 8.19%.

A number of research analysts recently weighed in on the company. Zacks Investment Research raised Cantel Medical from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical in a research note on Friday, September 1st. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Cantel Medical has an average rating of “Hold” and a consensus price target of $91.67.

In other Cantel Medical news, Director Mark N. Diker sold 7,000 shares of Cantel Medical stock in a transaction that occurred on Tuesday, October 3rd. The stock was sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Charles M. Diker sold 20,500 shares of Cantel Medical stock in a transaction that occurred on Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total value of $2,032,575.00. The disclosure for this sale can be found here. Insiders sold a total of 36,368 shares of company stock worth $3,576,028 over the last three months. 12.30% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: “6,842 Shares in Cantel Medical Corp. (CMD) Purchased by Raymond James Financial Services Advisors Inc.” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://theolympiareport.com/2017/12/05/6842-shares-in-cantel-medical-corp-cmd-purchased-by-raymond-james-financial-services-advisors-inc.html.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.